Chemical Formula: C21H18O3

Chemical Formula C21H18O3

Found 11 metabolite its formula value is C21H18O3

   
   

2,5-Bis(benzyloxy)benzenecarbaldehyde

2,5-Bis(benzyloxy)benzenecarbaldehyde

C21H18O3 (318.12558779999995)


   

2,3-bis(phenylmethoxy)benzaldehyde

2,3-bis(phenylmethoxy)benzaldehyde

C21H18O3 (318.12558779999995)


   

METHYL 4-(BENZYLOXY)-[1,1-BIPHENYL]-2-CARBOXYLATE

METHYL 4-(BENZYLOXY)-[1,1-BIPHENYL]-2-CARBOXYLATE

C21H18O3 (318.12558779999995)


   
   

3-(3,5-DIMETHOXYPHENYL)-1-(2-NAPHTHYL)PROP-2-EN-1-ONE

3-(3,5-DIMETHOXYPHENYL)-1-(2-NAPHTHYL)PROP-2-EN-1-ONE

C21H18O3 (318.12558779999995)


   

Benzoic acid,4-(phenylmethoxy)-, phenylmethyl ester

Benzoic acid,4-(phenylmethoxy)-, phenylmethyl ester

C21H18O3 (318.12558779999995)


   

(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid

(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid

C21H18O3 (318.12558779999995)


LT175, a dual PPARα/γ ligand, is an orally active partial agonist against PPARγ(hPPARα:EC50=0.22 μm; mPPARα:EC50=0.26 μm; hPPARγ:EC50=0.48 μm). LT175 interacts with PPARγ and affects the recruitment of the coregulators cyclic-AMP response element-binding protein-binding protein and nuclear corepressor 1 (NCoR1). LT175 interacts with PPARγ in a hydrophobic region called “diphenyl pocket”. LT175 has potent insulin-sensitizing effects and reduced adipogenic properties[1].

   

3-(6-Benzyloxy-naphthalen-2-yl)-acrylic acid methyl ester

3-(6-Benzyloxy-naphthalen-2-yl)-acrylic acid methyl ester

C21H18O3 (318.12558779999995)